| |
| |
|
| Insider
Information: |
Schrepfer Robert W |
| Relationship: |
|
| City: |
Baudette |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
87,477 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,882,828 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
87,477 |
|
|
| Total
Value |
$5,882,828 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ANI Pharmaceuticals Inc |
ANIP |
|
2021-03-29 |
87,477 |
2014-05-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANIP |
ANI Pharmaceuticals Inc |
SVP - NEW BUS DEV & SPEC SALES |
• – – |
2021-03-29 |
4 |
D |
$32.68 |
$181,897 |
D/D |
(5,566) |
87,477 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2020-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
39,767 |
93,043 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2020-04-07 |
4 |
D |
$43.93 |
$17,396 |
D/D |
(396) |
53,276 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2020-04-06 |
4 |
D |
$43.22 |
$28,785 |
D/D |
(666) |
53,672 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2020-03-31 |
4 |
D |
$40.74 |
$22,488 |
D/D |
(552) |
54,338 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2020-03-28 |
4 |
D |
$37.76 |
$39,157 |
D/D |
(1,037) |
54,890 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2019-05-13 |
4 |
S |
$71.13 |
$171,352 |
D/D |
(2,409) |
55,927 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2019-04-16 |
4 |
D |
$68.60 |
$24,696 |
D/D |
(360) |
58,336 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2019-04-07 |
4 |
D |
$70.50 |
$27,636 |
D/D |
(392) |
58,696 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2019-04-06 |
4 |
D |
$70.50 |
$46,460 |
D/D |
(659) |
59,088 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2019-03-31 |
4 |
D |
$70.54 |
$38,515 |
D/D |
(546) |
59,747 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2019-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
12,451 |
60,293 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2019-03-13 |
4 |
S |
$64.43 |
$299,646 |
D/D |
(4,651) |
47,842 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2019-03-13 |
4 |
OE |
$33.00 |
$153,483 |
D/D |
4,651 |
52,493 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2019-03-12 |
4 |
S |
$64.44 |
$460,522 |
D/D |
(7,145) |
47,842 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2019-03-12 |
4 |
OE |
$28.76 |
$211,863 |
D/D |
7,145 |
49,345 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2018-09-11 |
4 |
OE |
$6.60 |
$189,341 |
D/D |
28,688 |
47,842 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2018-05-22 |
4 |
D |
$61.88 |
$37,128 |
D/D |
(600) |
19,154 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2018-04-16 |
4 |
D |
$60.21 |
$14,872 |
D/D |
(247) |
19,754 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2018-04-07 |
4 |
D |
$57.06 |
$22,310 |
D/D |
(391) |
20,001 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2018-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
20,392 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2018-03-31 |
4 |
D |
$58.22 |
$31,788 |
D/D |
(546) |
12,392 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2018-03-01 |
4 |
S |
$60.33 |
$1,766,771 |
D/D |
(28,652) |
12,938 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2018-03-01 |
4 |
OE |
$28.76 |
$539,250 |
D/D |
18,750 |
41,590 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
SVP - New Bus Dev & Spec Sales |
• – – |
2017-05-22 |
4 |
D |
$47.01 |
$21,155 |
D/D |
(450) |
22,840 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
